Clinical Trial Update: A Folinic Acid Intervention for Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

A Phase 2 trial of folinic acid for autism spectrum disorders was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Folinic acid (folinic acid)

Snippet

Sponsor: University of Arkansas | Conditions: Autism Spectrum Disorder, Autistic Disorder | Phase 2 | Status: TERMINATED | Results posted: 2016-11-07